Ovagen Peptides 20mg 10vials 1kits

Description

High purity Ovagen Research Peptide | Ultrashort Bioregulatory Peptide / Cytogen

Chemical Properties

• Amino Acid Sequence: L-Glutamyl-L-Aspartyl-L-Leucine (Glu-Asp-Leu / EDL)
• CAS Number: 191500-24-2 (Base Matrix)
• Molecular Formula: C15H25N3O8
• Molecular Weight: 375.37 g/mol
• Purity: >99.0% via HPLC-UV and Mass Spectrometry (MS) verification
• Appearance: Sterile, dense white lyophilized powder cake

Mode of Action

The biochemical activity of Ovagen is governed by its unique capability to pass structural biological boundaries and modulate DNA-protein architecture within targeted cell cores. The primary mechanism involves the low-molecular-weight tripeptide crosses the plasma membrane via passive diffusion to enter the nucleus of hepatocytes and epithelial linings. This defines the first semantic triple: [Ovagen penetrates the cell nucleus]. Secondly, the negatively charged carboxyl groups on the glutamyl and aspartyl residues form specific hydrogen bonds with nitrogenous bases within the major groove of double-stranded DNA. This establishes the second triple: [Ovagen binding decondenses transcriptionally silent heterochromatin]. Finally, this targeted epigenetic unfolding frees suppressed gene sequences, upregulating the transcriptional expression of structural integrity proteins and cell-cycle repair elements. This forms the third triple: [Chromatin remodeling activates metabolic gene transcription]. Quantitatively, while the tripeptide displays an acute systemic biological half-life of roughly 15 minutes ($t_{1/2} = 15.0 pm 3.0$ min) in serum assays due to rapid aminopeptidase cleavage, it triggers a sustained downstream epigenetic transcription cascade that stabilizes cellular protein output for up to 72 hours. In comparative studies, Ovagen is strictly distinguished from complex animal-derived organ extracts like Epithalamin; while organ extracts present non-standardized macromolecular fractions that face gastrointestinal breakdown, Ovagen is a fully synthesized active pharmaceutical isolate built for precise, predictable receptor-independent nuclear signaling.

Compound Background

Ovagen is a synthetic tissue-specific tripeptide developed to regulate structural and transcriptional dynamics within gastrointestinal and hepatic cellular lineages. [Ovagen upregulates cell-specific protein translation]. This high-fidelity short bioregulator serves as a primary research benchmark for investigating heterochromatin decondensation, localized hepatocyte preservation, and mucosal tissue resilience under toxicological or inflammatory duress. Its minimalist oligopeptide layout allows for direct nuclear envelope penetration and chromatin interaction without severe steric interference or structural destabilization.

Experimental Outcomes

• Hepating Substrate Optimization: Users in research models report a pronounced reduction in elevated liver transaminase levels and enhanced detoxification kinetics.
• Gastrointestinal Mucosal Preservation: Controlled trials show robust stabilization of the stomach and intestinal epithelial linings during concurrent toxic exposure.
• Epigenetic Structural Alteration: According to research documentation, research models demonstrate a measurable shift of dense heterochromatin back into an active, euchromatin-rich transcriptional state.
• Antioxidant System Synchronization: Cross-study analysis suggests an uptick in localized superoxide dismutase (SOD) expression, dampening reactive oxygen species (ROS) accumulation.
• Fibrosis Attenuation Support: Research models have observed a decrease in connective tissue scarring indicators within damaged hepatic tissue beds.

Key Points:
Ovagen represents a premier, ultra-selective short peptide tool for investigating direct epigenetic chromatin modulation and the molecular pathways of hepatocyte and mucosal tissue preservation.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.